Clinical Trials on HER2 Mutation-Related Tumors
Total 2404 results
-
Regeneron PharmaceuticalsPacific Pediatric Neuro-Oncology ConsortiumTerminatedHigh Grade Glioma | Diffuse Intrinsic Pontine Glioma | Relapsed Solid Tumor | Refractory Solid Tumor | Relapsed Central Nervous System Tumor | Refractory Central Nervous System TumorUnited States
-
National Cancer Institute (NCI)Active, not recruitingMetastatic Digestive System Neuroendocrine Tumor G1 | Recurrent Digestive System Neuroendocrine Tumor G1 | Regional Digestive System Neuroendocrine Tumor G1 | Metastatic Neuroendocrine Tumor | Midgut Neuroendocrine Tumor G1 | Foregut Neuroendocrine Tumor | Hindgut Neuroendocrine Tumor | Neuroendocrine...Canada, United States
-
The First Affiliated Hospital with Nanjing Medical...RecruitingBreast Cancer | HER2-positive Breast Cancer | Circulating Tumor DNA | NeoadjuvantChina
-
First Affiliated Hospital of Zhejiang UniversityRecruitingBreast Cancer | HER2-positive Breast Cancer | Estrogen Receptor Positive TumorChina
-
Fondazione IRCCS Istituto Nazionale dei Tumori,...UnknownTesticular Germ Cell Tumor | Brain and Central Nervous System Tumors | Extragonadal Germ Cell TumorItaly
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)CompletedUnspecified Childhood Solid Tumor, Protocol Specific | Testicular Germ Cell Tumor | Ovarian Cancer | Brain and Central Nervous System Tumors | Unspecified Adult Solid Tumor, Protocol Specific | Retinoblastoma | Extragonadal Germ Cell Tumor | Childhood Germ Cell TumorUnited States
-
Fondazione IRCCS Istituto Nazionale dei Tumori,...Active, not recruitingWell Differentiated Pancreatic Endocrine TumorItaly
-
Cambridge University Hospitals NHS Foundation TrustCompletedIslet Cell Tumor | Gastrointestinal Carcinoid TumorUnited Kingdom
-
Novartis PharmaceuticalsCompleted
-
British Columbia Cancer AgencyWithdrawnNeuroendocrine Tumors | Carcinoid Tumor | Gastrinoma | Insulinoma | Vipoma | Gastroenteropancreatic Neuroendocrine Tumor | Pulmonary Carcinoid TumorCanada
-
AC Camargo Cancer CenterRecruitingProgression | Neuroendocrine Tumors | Neuroendocrine Tumor of the Lung | Neuroendocrine Tumor Grade 2 | Neuroendocrine Tumor Grade 1 | Neuroendocrine Tumor of Pancreas | Neuroendocrine Tumor CarcinoidBrazil
-
ETOP IBCSG Partners FoundationPfizer; Hoffmann-La RocheCompletedBreast Cancer | HER2-positive Breast Cancer | Estrogen Receptor Positive TumorFrance, Switzerland, Belgium, Italy
-
David BushnellNational Cancer Institute (NCI); Holden Comprehensive Cancer Center; Perspective...Active, not recruitingNeuroendocrine Tumors | Neuroendocrine Tumor of the Lung | Neuroendocrine Tumor Grade 2 | Neuroendocrine Tumor Grade 1 | Neuroendocrine Tumor of PancreasUnited States
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)CompletedTesticular Germ Cell Tumor | Ovarian Cancer | Brain and Central Nervous System Tumors | Extragonadal Germ Cell TumorUnited States
-
University of SouthamptonUniversity Hospital Southampton NHS Foundation TrustUnknownTesticular Germ Cell Tumor | Ovarian Cancer | Brain and Central Nervous System Tumors | Extragonadal Germ Cell TumorUnited Kingdom
-
Ohio State University Comprehensive Cancer CenterNational Cancer Institute (NCI)CompletedIslet Cell Tumor | Gastrointestinal Carcinoid TumorUnited States
-
Lei LiUnknownEpithelial Ovarian Cancer | Progression-free Survival | Epithelial Ovarian Tumor of Borderline Malignancy | Driving MutationsChina
-
European Institute of OncologyActive, not recruitingNeuroendocrine Tumor of Pancreas | Neuroendocrine Tumor Carcinoid | Gep NetItaly
-
Shanghai Juncell TherapeuticsRecruitingMelanoma | Efficacy | Adverse Drug Event | Safety | Tumor Infiltrating LymphocytesChina
-
Qianqian QuNot yet recruitingMalignant Tumor of the Ovary | XRCC2 Gene Mutation
-
University of California, San FranciscoSanofi; Genentech, Inc.TerminatedLung Cancer | Neuroendocrine Tumor | Islet Cell Tumor | Gastrointestinal Carcinoid Tumor | Neoplastic SyndromeUnited States
-
National University Hospital, SingaporeAdagene IncActive, not recruitingAdvanced Solid Tumor | HER2-negative Breast CancerSingapore
-
US Department of Veterans AffairsCompletedLeg Injuries | Diabetes Mellitus | Traumatic AmputationUnited States
-
Baylor College of MedicineCancer Prevention Research Institute of Texas; The Methodist Hospital Research... and other collaboratorsActive, not recruitingRefractory Neuroblastoma | Uveal Melanoma | Relapsed Ewing Sarcoma | Relapsed Osteosarcoma | Relapsed Neuroblastoma | Relapsed Rhabdomyosarcoma | Phyllodes Breast TumorUnited States
-
Cancer Institute and Hospital, Chinese Academy...Not yet recruitingNon Small Cell Lung Cancer | ERBB2 Mutation-Related Tumors | Disitamab Vedotin | ERBB2 Gene Duplication
-
Sun Yat-sen UniversityNot yet recruitingNon Small Cell Lung Cancer | ERBB2 Mutation-Related Tumors | RC48 | Disitamab VedotinChina
-
Gangnam Severance HospitalSamsung Medical Center; Asan Medical Center; Severance HospitalRecruitingBreast Cancer | Surgery | Recurrent Breast Cancer | Estrogen Receptor Positive Tumor | Stereotactic Body Radiotherapy | Her2-negative TumorKorea, Republic of
-
Hospices Civils de LyonRecruiting
-
City of Hope Medical CenterNational Cancer Institute (NCI)TerminatedSarcoma | Lymphoma | Kidney Cancer | Unspecified Childhood Solid Tumor, Protocol Specific | Testicular Germ Cell Tumor | Ovarian Cancer | Brain and Central Nervous System Tumors | Neuroblastoma | Liver Cancer | Extragonadal Germ Cell Tumor | Childhood Germ Cell TumorUnited States
-
Crinetics Pharmaceuticals Inc.Active, not recruitingCarcinoid Tumor | Carcinoid Syndrome | Carcinoid | Carcinoid Tumor of Ileum | Carcinoid Tumor of Cecum | Carcinoid Syndrome Diarrhea | Carcinoid Intestine Tumor | Carcinoid Tumor of Liver | Carcinoid Tumor of PancreasUnited States, Brazil, Argentina, Canada, Mexico, Peru, Poland
-
Fondazione Policlinico Universitario Agostino Gemelli...RecruitingOvarian Cancer | Ultrasound Therapy; Complications | BRCA MutationItaly
-
Samsung Medical CenterActive, not recruitingHER2-positive Breast Cancer | Chemotherapy Effect | Circulating Tumor DNAKorea, Republic of
-
National Institutes of Health Clinical Center (CC)National Cancer Institute (NCI)CompletedSarcoma | Kidney Cancer | Unspecified Childhood Solid Tumor, Protocol Specific | Leukemia | Ovarian Cancer | Brain and Central Nervous System Tumors | Neuroblastoma | Liver Cancer | Extragonadal Germ Cell Tumor | Childhood Germ Cell TumorUnited States
-
Eastern Cooperative Oncology GroupNational Cancer Institute (NCI)CompletedIslet Cell Tumor | Gastrointestinal Carcinoid Tumor | Neoplastic SyndromeUnited States
-
Federation Francophone de Cancerologie DigestiveCompletedIslet Cell Tumor | Gastrointestinal Carcinoid Tumor | Neoplastic Syndrome
-
University Hospital, BrestCompleted
-
Jiangsu HengRui Medicine Co., Ltd.Not yet recruitingNon-Small Cell Lung Cancer With HER2- MutationsChina
-
National Cancer Institute (NCI)CompletedLocally Advanced Pancreatic Neuroendocrine Tumor | Pancreatic Neuroendocrine Tumor G1 | Pancreatic Neuroendocrine Tumor G2 | Pancreatic Vipoma | Pancreatic Gastrinoma | Advanced Pancreatic Neuroendocrine TumorUnited States, Canada
-
Guangxi Medical UniversityRecruitingPancreatic Neuroendocrine Tumor | Nonfunctional Pancreatic Neuroendocrine Tumor | Endoscopic UltrasoundChina
-
Vanderbilt-Ingram Cancer CenterEntrinsic Bioscience Inc.TerminatedNeuroendocrine Tumor | Carcinoid SyndromeUnited States
-
Acerand Therapeutics (Shanghai) LimitedRecruitingBreast Cancer | Ovarian Cancer | Prostate Cancer | BRCA1 Mutation | BRCA2 Mutation | Solid Tumor, AdultChina
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingBreast Carcinoma | Fallopian Tube Carcinoma | Endometrial Carcinoma | Ovarian Carcinoma | Primary Peritoneal Carcinoma | Deleterious CDH1 Gene Mutation | Deleterious DICER1 Gene Mutation | Deleterious SMARCA4 Gene Mutation | Deleterious STK11 Gene MutationUnited States
-
National Cancer Institute (NCI)TerminatedMetastatic Melanoma | Stage III Cutaneous Melanoma AJCC v7 | Stage IV Cutaneous Melanoma AJCC v6 and v7 | Stage IIIC Cutaneous Melanoma AJCC v7 | BRAF V600E Mutation Present | BRAF V600K Mutation Present | Stage IIIA Cutaneous Melanoma AJCC v7 | Stage IIIB Cutaneous Melanoma AJCC v7United States
-
Aadi Bioscience, Inc.RecruitingNeuroendocrine Tumors | Pancreatic Neuroendocrine Tumor | Gastrointestinal Neuroendocrine Tumor | NET | Pulmonary Neuroendocrine TumorUnited States
-
Eastern Cooperative Oncology GroupNational Cancer Institute (NCI)WithdrawnGastrointestinal Carcinoid Tumor | Islet Cell Carcinoma
-
National Heart Centre SingaporeSingapore General Hospital; Duke-NUS Graduate Medical SchoolCompletedObesity | Diabetes | Dyslipidemia | Mutation
-
National Cancer Institute (NCI)CompletedBRCA1 Gene Mutation | BRCA2 Gene Mutation | Recurrent Breast Carcinoma | Estrogen Receptor Negative | Estrogen Receptor Positive | HER2/Neu Negative | Progesterone Receptor Negative | Progesterone Receptor Positive | Triple-Negative Breast Carcinoma | Stage IV Breast Cancer AJCC v6 and v7 | Stage IIIB Breast... and other conditionsUnited States
-
Stephen Bagley, MD, MSCEUniversity of Pennsylvania; Incyte CorporationRecruitingGlioma | Astrocytoma | Oligodendroglioma | IDH MutationUnited States
-
Second Xiangya Hospital of Central South UniversityThe First Affiliated Hospital of Nanchang University; Xiangya Hospital of Central... and other collaboratorsRecruitingLung Cancer, Non-small Cell | Circulating Tumor DNA | EGFR Gene Mutation | EGFR-TKI Resistant Mutation | Primary ResistanceChina
-
AIPING ZHOUNot yet recruitingImmunotherapy | Sintilimab | Locally Advanced Solid Tumor | Oxaliplatin | HER2-positive | Gastric or Gastroesophageal Junction Adenocarcinoma | S-1China